首页> 外文期刊>Endoscopy: Journal for Clinical Use Biopsy and Technique >A systematic review on endoscopic detection rate, endotherapy, and surgery for pancreas divisum.
【24h】

A systematic review on endoscopic detection rate, endotherapy, and surgery for pancreas divisum.

机译:关于胰腺癌的内镜检出率,内治疗和手术的系统评价。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND AND STUDY AIMS: The rates for endoscopic detection of pancreas divisum at routine endoscopic retrograde cholangiopancreatography (ERCP) vary worldwide, and the sample sizes in the reported studies on endoscopy and surgery for pancreas divisum are very small and variable. The aim of this study was to systematically analyze the pooled data and determine endoscopic detection rates for pancreas divisum and pain relief rates in patients with pancreas divisum after endotherapy or surgery. MATERIALS AND METHODS: A search for published data was performed by using the Medline database (1950 to 1st May 2008) with "pancreas divisum" as the keyword. Publications, mainly on endoscopic detection rate, endotherapy, or surgery for pancreas divisum, were deemed relevant, and were further fully reviewed and analyzed. RESULTS: A total of 615 abstracts were retrieved from Medline; 17 articles on endoscopic detection rate, 15 articles on endotherapy, and 13 articles on surgery were included in the review and analysis. The overall endoscopic detection rate for pancreas divisum was 2.9% (899/31,413), with the rate being significantly higher in the United States (5.8%) and Europe (6.0%) than in Asia (1.5%) (both P < 0.001). The pooled overall response rates (i. e. complete and partial pain relief rates after treatment) to endotherapy (69.4%, 361/520) and surgery (74.9%, 203/271) were similar (P = 0.106). In addition, there were significant differences in the combined response rates (for endotherapy and for surgery) between patients with pancreas divisum of acute recurrent pancreatitis (ARP)-type (81.2 %) compared with chronic pancreatitis-type (68.8%), and between ARP-type and pain-type (53.1%) (both P < 0.05). CONCLUSIONS: The endoscopic detection rate for pancreas divisum is much higher in western countries than in Asian countries. The pooled response rates of patients with pancreas divisum to endotherapy and surgery are similar in the reported series. Patients with ARP-type pancreas divisum respond better to endotherapy or surgery than those with chronic pancreatitis-type and pain-type.
机译:背景和研究目的:常规内镜逆行胰胆管造影术(ERCP)内镜检查胰脏的比率在世界范围内有所不同,并且已报道的胰脏内镜和外科手术研究的样本量非常小且变化很大。这项研究的目的是系统地分析汇总的数据,并确定内镜治疗或手术后胰脏分裂的患者的内镜检出率和胰脏分裂的疼痛缓解率。材料与方法:使用Medline数据库(1950年至2008年5月1日),以“胰脏分裂”为关键词,对公开数据进行搜索。主要涉及内窥镜检出率,内治疗或胰脏分裂手术的出版物被认为是相关的,并作了进一步的全面审查和分析。结果:从Medline检索了615个摘要。回顾和分析包括17篇关于内镜检出率的文章,15篇关于内科治疗的文章和13篇关于外科手术的文章。胰内镜检查的总内窥镜检出率为2.9%(899 / 31,413),其中美国(5.8%)和欧洲(6.0%)的比率显着高于亚洲(1.5%)(P <0.001) 。对内治疗(69.4%,361/520)和手术(74.9%,203/271)的总总体缓解率(即治疗后完全缓解和部分缓解的缓解率)相似(P = 0.106)。此外,急性复发性胰腺炎(ARP)型胰腺分裂患者(81.2%)与慢性胰腺炎类型(68.8%)的胰腺分裂患者之间的综合反应率(内治疗和手术)之间存在显着差异ARP型和疼痛型(53.1%)(均P <0.05)。结论:西方国家内窥镜检查胰脏的检出率远高于亚洲国家。在报告的系列中,胰脏分裂患者对内治疗和手术的综合反应率相似。 ARP型胰腺分裂症患者对内疗法或外科手术的反应优于慢性胰腺炎类型和疼痛型患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号